320-x-100_uti_gold.jpg" alt="Advertisement">
04-05-2021 07:15 PM | Source: (Reuters)
India's Panacea Biotec to produce 100 million Sputnik V doses annually - RDIF
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
MOSCOW - Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
RDIF did not say when production would begin.
(Reporting by Vladimir Soldatkin; Writing by Alexander Marrow, ediitng by Emelia Sithole-Matarise)
Latest News
Nail Fashion Trends: The Art of Expressing Style Thr...
Sustainable Living: Tips for a Greener Lifestyle
PM Narendra Modi to attend Christmas celebrations ho...
Government launching 3 apps to protect consumers in ...
Kia to launch compact SUV `Syros` in India next year
GST recommendations to create business-friendly envi...
CII seeks priority sector lending for new and emergi...
The Wealth of Experiences: How Travel and Cultural E...
India`s tax panel rejects airlines` call to add avia...
Rozgar Mela: PM Narendra Modi to distribute 71,000 a...
